EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 6th, 2015 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is entered into as of July 20, 2015 (the “Effective Date”) by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and Mr. Matthew M. Loar, an individual (the “Executive”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2015 Company IndustryThis Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into as of July 31, 2015 by and between OXiGENE, Inc., a Delaware corporation, (the “Company”), and Dr. William Schwieterman, an individual (the “Executive”).
SEPARATION AGREEMENT AND RELEASESeparation Agreement • August 6th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2015 Company IndustryTHIS SEPARATION AGREEMENT AND RELEASE (“Agreement”) is made and entered into by and between Barbara Riching (“Employee”) and OXiGENE, Inc. (“Company”), and inures to the benefit of each of Company’s current, former and future, as applicable, subsidiaries, affiliates, related entities, successors, officers, directors, shareholders, agents, employees and assigns. The term “Parties” used in this Agreement means Company and Employee collectively.